Literature DB >> 25052591

Regulating the diverse outcomes of interferon's interference.

Heather D Marshall1, Susan M Kaech2.   

Abstract

Regulatory T cells are crucial for preventing autoimmunity, but how their function is restrained to allow optimal effector T cells responses in appropriate contexts is unclear. In a recent paper in the Journal of Experimental Medicine, Campbell and colleagues demonstrate that virus-induced type I interferon acts directly on Treg cells to allow for functional antiviral T cell responses.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25052591      PMCID： PMC4267687          DOI： 10.1016/j.it.2014.07.002

Source DB:  PubMed          Journal:  Trends Immunol        ISSN： 1471-4906            Impact factor:   16.687


  10 in total

1.  IFN-induced attrition of CD8 T cells in the presence or absence of cognate antigen during the early stages of viral infections.

Authors:  Kapil Bahl; Sung-Kwon Kim; Claudia Calcagno; Dario Ghersi; Roberto Puzone; Franco Celada; Liisa K Selin; Raymond M Welsh
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

2.  Type I interferon protects antiviral CD8+ T cells from NK cell cytotoxicity.

Authors:  Haifeng C Xu; Melanie Grusdat; Aleksandra A Pandyra; Robin Polz; Jun Huang; Piyush Sharma; René Deenen; Karl Köhrer; Ramtin Rahbar; Andreas Diefenbach; Kathrin Gibbert; Max Löhning; Lena Höcker; Zoe Waibler; Dieter Häussinger; Tak W Mak; Pamela S Ohashi; Karl S Lang; Philipp A Lang
Journal:  Immunity       Date:  2014-06-05       Impact factor: 31.745

3.  Type I interferons protect T cells against NK cell attack mediated by the activating receptor NCR1.

Authors:  Josh Crouse; Gregor Bedenikovic; Melanie Wiesel; Mark Ibberson; Ioannis Xenarios; Dorothee Von Laer; Ulrich Kalinke; Eric Vivier; Stipan Jonjic; Annette Oxenius
Journal:  Immunity       Date:  2014-06-05       Impact factor: 31.745

4.  Analysis of apoptosis of memory T cells and dendritic cells during the early stages of viral infection or exposure to toll-like receptor agonists.

Authors:  Kapil Bahl; Anette Hüebner; Roger J Davis; Raymond M Welsh
Journal:  J Virol       Date:  2010-03-03       Impact factor: 5.103

5.  Virus-induced transient immune suppression and the inhibition of T cell proliferation by type I interferon.

Authors:  Heather D Marshall; Stina L Urban; Raymond M Welsh
Journal:  J Virol       Date:  2011-04-06       Impact factor: 5.103

6.  Regulating type 1 IFN effects in CD8 T cells during viral infections: changing STAT4 and STAT1 expression for function.

Authors:  M Pilar Gil; Mickaël J Y Ploquin; Wendy T Watford; Seung-Hwan Lee; Kwangsin Kim; Xin Wang; Yuka Kanno; John J O'Shea; Christine A Biron
Journal:  Blood       Date:  2012-09-11       Impact factor: 22.113

Review 7.  Role of regulatory T cells during virus infection.

Authors:  Tamara Veiga-Parga; Sharvan Sehrawat; Barry T Rouse
Journal:  Immunol Rev       Date:  2013-09       Impact factor: 12.988

8.  Memory CD8 T-cell compartment grows in size with immunological experience.

Authors:  Vaiva Vezys; Andrew Yates; Kerry A Casey; Gibson Lanier; Rafi Ahmed; Rustom Antia; David Masopust
Journal:  Nature       Date:  2008-11-12       Impact factor: 49.962

9.  Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection.

Authors:  Ganesh A Kolumam; Sunil Thomas; Lucas J Thompson; Jonathan Sprent; Kaja Murali-Krishna
Journal:  J Exp Med       Date:  2005-08-29       Impact factor: 14.307

10.  Type I interferons directly inhibit regulatory T cells to allow optimal antiviral T cell responses during acute LCMV infection.

Authors:  Shivani Srivastava; Meghan A Koch; Marion Pepper; Daniel J Campbell
Journal:  J Exp Med       Date:  2014-04-07       Impact factor: 14.307
  10 in total
  1 in total

Review 1.  HIV-1 and interferons: who's interfering with whom?

Authors:  Tomas Doyle; Caroline Goujon; Michael H Malim
Journal:  Nat Rev Microbiol       Date:  2015-04-27       Impact factor: 60.633
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.